This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Arizona State University, Oncomyx Therapeutics, Inc.. Active years: 2021-2025.
Company Filing History:
2 out of 2,154 
1 out of 1 Years Active: 2021-2025
Title: Lino Torres-Dominguez: Innovator in Oncolytic Virus Research
Introduction
Lino Torres-Dominguez is a notable inventor based in Tempe, AZ (US). He has made significant contributions to the field of cancer treatment through his innovative work on oncolytic viruses. With a total of 2 patents, his research focuses on utilizing myxoma viruses to develop effective therapies for cancer patients.
Latest Patents
Lino's latest patents revolve around an oncolytic virus platform designed to treat cancers using myxoma virus. The patents disclose recombinant myxoma viruses (MYXVs) and nucleic acid constructs encoding these viruses. In certain embodiments, the MYXVs are engineered to inactivate or attenuate the activity or expression level of an M153 protein. Additionally, the MYXVs can express transgenes such as tumor necrosis factor (TNF), interleukin-12 (IL-12), or decorin. The patents also outline methods for using MYXVs, including providing a MYXV to a subject in need of treatment.
Career Highlights
Lino has worked with prominent organizations such as Arizona State University and Oncomyx Therapeutics, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Lino has collaborated with esteemed colleagues, including Mohammed Masmudur Rahman and Leslie Lynne Sharp. These partnerships have enriched his research and fostered innovation in the field of oncolytic virus therapy.
Conclusion
Lino Torres-Dominguez is a pioneering inventor whose work on myxoma viruses has the potential to transform cancer treatment. His dedication to research and collaboration continues to drive advancements in the field.